Recent developments centered on orally active iron chelators
Over the past twenty years there has been a growing interest in the orally active iron chelators, deferiprone and deferasirox, both have been extensively studied. The ability of these compounds to mobilize iron from the heart and endocrine tissue has presented the clinician with some advantages over...
| Hlavní autor: | |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
MDPI AG
2014-09-01
|
| Edice: | Thalassemia Reports |
| Témata: | |
| On-line přístup: | http://www.pagepressjournals.org/index.php/thal/article/view/2261 |